| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 162 |
| 1 | ALENDRONATE SODIUM | 134 |
| 2 | OMEPRAZOLE MAGNESIUM | 65 |
| 3 | ASPIRIN | 54 |
| 4 | ASPIRIN 325 MG | 52 |
| 5 | ASPIRIN 81 MG | 52 |
| 6 | LETROZOLE | 51 |
| 7 | PREDNISONE | 51 |
| 8 | ACETAMINOPHEN | 47 |
| 9 | GABAPENTIN | 44 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OXYCODONE AND ASPIRIN | 1 | 0.0196 |
| 1 | SENNOSIDES, STIMULANT LAXATIVE | 1 | 0.0139 |
| 2 | ASPRIN AND CAFFEINE | 1 | 0.0082 |
| 3 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 18 | 0.0065 |
| 4 | CLINDAMYCIN PHOSPHATE | 32 | 0.0058 |
| 5 | PAMIDRONATE DISODIUM | 18 | 0.0053 |
| 6 | IBANDRONATE SODIUM | 12 | 0.0038 |
| 7 | LINCOMYCIN HYDROCHLORIDE | 1 | 0.0034 |
| 8 | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | 1 | 0.0030 |
| 9 | PSYLLIUM HUSK | 4 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | RANK Ligand Inhibitor [EPC] | 162 |
| 1 | Corticosteroid [EPC] | 146 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 140 |
| 3 | Aromatase Inhibitor [EPC] | 83 |
| 4 | Benzodiazepine [EPC] | 71 |
| 5 | Proton Pump Inhibitor [EPC] | 65 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 58 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 56 |
| 8 | Opioid Agonist [EPC] | 53 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 50 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon gamma [EPC] | 3 | 0.0021 |
| 1 | Provitamin D2 Compound [EPC] | 37 | 0.0012 |
| 2 | RANK Ligand Inhibitor [EPC] | 162 | 0.0008 |
| 3 | Aromatase Inhibitor [EPC] | 83 | 0.0007 |
| 4 | Estrogen Receptor Antagonist [EPC] | 21 | 0.0005 |
| 5 | Sulfonamide Antibacterial [EPC] | 2 | 0.0005 |
| 6 | Androgen Receptor Inhibitor [EPC] | 27 | 0.0004 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 9 | Calcitonin [EPC] | 1 | 0.0003 |